ARGENX SE (ARGX.BR) Stock Fundamental Analysis

EBR:ARGX • NL0010832176

709.8 EUR
-0.4 (-0.06%)
Last: Feb 18, 2026, 12:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ARGX. ARGX was compared to 78 industry peers in the Biotechnology industry. ARGX has an excellent financial health rating, but there are some minor concerns on its profitability. ARGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes ARGX very considerable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ARGX was profitable.
  • ARGX had a positive operating cash flow in the past year.
  • ARGX had negative earnings in 4 of the past 5 years.
  • ARGX had a negative operating cash flow in each of the past 5 years.
ARGX.BR Yearly Net Income VS EBIT VS OCF VS FCFARGX.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

  • The Return On Assets of ARGX (17.84%) is better than 93.59% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.00%, ARGX belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • ARGX's Return On Invested Capital of 5.71% is amongst the best of the industry. ARGX outperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA 17.84%
ROE 21%
ROIC 5.71%
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ARGX.BR Yearly ROA, ROE, ROICARGX.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • ARGX has a Profit Margin of 41.97%. This is amongst the best in the industry. ARGX outperforms 94.87% of its industry peers.
  • ARGX has a Operating Margin of 15.30%. This is amongst the best in the industry. ARGX outperforms 85.90% of its industry peers.
  • ARGX has a better Gross Margin (89.40%) than 83.33% of its industry peers.
Industry RankSector Rank
OM 15.3%
PM (TTM) 41.97%
GM 89.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARGX.BR Yearly Profit, Operating, Gross MarginsARGX.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • ARGX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ARGX has more shares outstanding
  • The number of shares outstanding for ARGX has been increased compared to 5 years ago.
  • The debt/assets ratio for ARGX is higher compared to a year ago.
ARGX.BR Yearly Shares OutstandingARGX.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ARGX.BR Yearly Total Debt VS Total AssetsARGX.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • ARGX has an Altman-Z score of 30.31. This indicates that ARGX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ARGX (30.31) is better than 94.87% of its industry peers.
  • The Debt to FCF ratio of ARGX is 0.14, which is an excellent value as it means it would take ARGX, only 0.14 years of fcf income to pay off all of its debts.
  • ARGX has a Debt to FCF ratio of 0.14. This is amongst the best in the industry. ARGX outperforms 93.59% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that ARGX is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.01, ARGX belongs to the best of the industry, outperforming 85.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Altman-Z 30.31
ROIC/WACC0.77
WACC7.43%
ARGX.BR Yearly LT Debt VS Equity VS FCFARGX.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

  • ARGX has a Current Ratio of 5.60. This indicates that ARGX is financially healthy and has no problem in meeting its short term obligations.
  • ARGX's Current ratio of 5.60 is amongst the best of the industry. ARGX outperforms 83.33% of its industry peers.
  • A Quick Ratio of 5.27 indicates that ARGX has no problem at all paying its short term obligations.
  • ARGX's Quick ratio of 5.27 is amongst the best of the industry. ARGX outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 5.27
ARGX.BR Yearly Current Assets VS Current LiabilitesARGX.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1512.50% over the past year.
  • Looking at the last year, ARGX shows a very strong growth in Revenue. The Revenue has grown by 64.71%.
  • ARGX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.61% yearly.
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%

3.2 Future

  • Based on estimates for the next years, ARGX will show a very strong growth in Earnings Per Share. The EPS will grow by 103.40% on average per year.
  • Based on estimates for the next years, ARGX will show a very strong growth in Revenue. The Revenue will grow by 35.36% on average per year.
EPS Next Y934.93%
EPS Next 2Y316.29%
EPS Next 3Y180.77%
EPS Next 5Y103.4%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y35.36%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ARGX.BR Yearly Revenue VS EstimatesARGX.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ARGX.BR Yearly EPS VS EstimatesARGX.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 40 60 80

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • ARGX is valuated quite expensively with a Price/Earnings ratio of 67.54.
  • Based on the Price/Earnings ratio, ARGX is valued cheaply inside the industry as 80.77% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.16. ARGX is valued rather expensively when compared to this.
  • ARGX is valuated quite expensively with a Price/Forward Earnings ratio of 28.00.
  • Based on the Price/Forward Earnings ratio, ARGX is valued cheaply inside the industry as 82.05% of the companies are valued more expensively.
  • ARGX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.10.
Industry RankSector Rank
PE 67.54
Fwd PE 28
ARGX.BR Price Earnings VS Forward Price EarningsARGX.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARGX is valued a bit cheaper than 78.21% of the companies in the same industry.
  • ARGX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ARGX is cheaper than 80.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 168.26
EV/EBITDA 94.61
ARGX.BR Per share dataARGX.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • ARGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ARGX's earnings are expected to grow with 180.77% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y316.29%
EPS Next 3Y180.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ARGX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARGENX SE

EBR:ARGX (2/18/2026, 12:07:57 PM)

709.8

-0.4 (-0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners43.42%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap43.92B
Revenue(TTM)3.60B
Net Income(TTM)1.28B
Analysts84
Price Target876.91 (23.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)5.02%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)5.96%
Revenue beat(12)10
Avg Revenue beat(12)14%
Revenue beat(16)13
Avg Revenue beat(16)17.53%
PT rev (1m)4.76%
PT rev (3m)18.81%
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)-0.95%
EPS NY rev (1m)0%
EPS NY rev (3m)6.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.97%
Valuation
Industry RankSector Rank
PE 67.54
Fwd PE 28
P/S 17.03
P/FCF 168.26
P/OCF 128.66
P/B 8.52
P/tB 8.84
EV/EBITDA 94.61
EPS(TTM)10.51
EY1.48%
EPS(NY)25.35
Fwd EY3.57%
FCF(TTM)4.22
FCFY0.59%
OCF(TTM)5.52
OCFY0.78%
SpS41.69
BVpS83.29
TBVpS80.3
PEG (NY)0.07
PEG (5Y)N/A
Graham Number140.35
Profitability
Industry RankSector Rank
ROA 17.84%
ROE 21%
ROCE 7.61%
ROIC 5.71%
ROICexc 15.87%
ROICexgc 17.62%
OM 15.3%
PM (TTM) 41.97%
GM 89.4%
FCFM 10.12%
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Debt/EBITDA 0.07
Cap/Depr 428.74%
Cap/Sales 3.12%
Interest Coverage 519.07
Cash Conversion 82.6%
Profit Quality 24.11%
Current Ratio 5.6
Quick Ratio 5.27
Altman-Z 30.31
F-Score6
WACC7.43%
ROIC/WACC0.77
Cap/Depr(3y)176.19%
Cap/Depr(5y)545.91%
Cap/Sales(3y)10.66%
Cap/Sales(5y)13.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y934.93%
EPS Next 2Y316.29%
EPS Next 3Y180.77%
EPS Next 5Y103.4%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y35.36%
EBIT growth 1Y208.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1529.77%
EBIT Next 3Y219.36%
EBIT Next 5Y126.87%
FCF growth 1Y140.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.76%
OCF growth 3YN/A
OCF growth 5YN/A

ARGENX SE / ARGX.BR FAQ

What is the fundamental rating for ARGX stock?

ChartMill assigns a fundamental rating of 6 / 10 to ARGX.BR.


What is the valuation status for ARGX stock?

ChartMill assigns a valuation rating of 6 / 10 to ARGENX SE (ARGX.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for ARGENX SE?

ARGENX SE (ARGX.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of ARGENX SE (ARGX.BR) stock?

The Price/Earnings (PE) ratio for ARGENX SE (ARGX.BR) is 67.54 and the Price/Book (PB) ratio is 8.52.


What is the earnings growth outlook for ARGENX SE?

The Earnings per Share (EPS) of ARGENX SE (ARGX.BR) is expected to grow by 934.93% in the next year.